| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Royal Manchester Childrens Hospital (C.M.H., J.A.J., D.A.P., P.E.C.), Manchester M27 4HA, Regional Molecular Genetics Laboratory (M.C.), St. Marys Hospital, Manchester M13 0JH, and Department of Mathematics (P.F.), University of Manchester, Manchester M13 9PL, United Kingdom; and Department of Psychiatry (H.F.L.M.-B., C.D.), Columbia University, New York, New York 10027
Address all correspondence and requests for reprints to: Catherine M. Hall, Endocrine Department, Royal Manchester Childrens Hospital, Manchester M27 4HA, United Kingdom. E-mail: catherine.hall{at}cmmc.nhs.uk.
Girls with congenital adrenal hyperplasia (CAH) exhibit behavioral masculinization. There is controversy about the roles of pre- and postnatal androgens, social factors, and chronic illness in its etiology.
To assess the effect of chronic illness, we compared behavioral masculinity in 24 CAH girls and 25 diabetic girls aged 312 yr from Manchester using two sensitive questionnaires, and an overall masculinity score M (high = masculine) was derived.
To assess the contributions of pre- and postnatal androgens, the CAH subjects were categorized into genotype groups (G) according to the reported severity of loss of CYP21 function: G1 (n = 10, null mutations), G2 (n = 9, intron 2G), G3 (n = 3, I172N), and G4 (n = 2, unknown loss of function). In CAH girls, relationships between G, Prader degree of genital masculinization at birth, bone age advance, and M were assessed.
CAH girls were less feminine and more masculine than diabetic girls (P < 0.001), who were not significantly different from U.S. controls. Among the CAH girls, those in G1 and 2 were more genitally masculinized than those in G3 and 4 (P < 0.009) and had higher M (P < 0.025). M was negatively correlated with advanced bone age (r = -0.5; P = 0.02).
CAH girls, but not diabetic girls, demonstrated behavioral masculinization. Both physical and behavioral masculinization were related to each other and to genotype, indicating that behavioral masculinization is a consequence of prenatal androgen exposure.
Abbreviations: CAH, Congenital adrenal hyperplasia; 17OHP, 17-hydroxyprogesterone.
This article has been cited by other articles:
![]() |
C. Ciumas, A. L. Hirschberg, and I. Savic High Fetal Testosterone and Sexually Dimorphic Cerebral Networks in Females Cereb Cortex, May 1, 2009; 19(5): 1167 - 1174. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. L. Claahsen-van der Grinten, K. Noordam, G. F. Borm, and B. J. Otten Absence of Increased Height Velocity in the First Year of Life in Untreated Children with Simple Virilizing Congenital Adrenal Hyperplasia J. Clin. Endocrinol. Metab., April 1, 2006; 91(4): 1205 - 1209. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.H. Abbott, D.K. Barnett, C.M. Bruns, and D.A. Dumesic Androgen excess fetal programming of female reproduction: a developmental aetiology for polycystic ovary syndrome? Hum. Reprod. Update, July 1, 2005; 11(4): 357 - 374. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. Forest Recent advances in the diagnosis and management of congenital adrenal hyperplasia due to 21-hydroxylase deficiency Hum. Reprod. Update, November 1, 2004; 10(6): 469 - 485. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |